Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-040665
Filing Date
2025-04-29
Accepted
2025-04-29 08:06:39
Documents
2
Period of Report
2025-04-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2513375-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2513375-1_3seq1.xml 3 1574
2 EXHIBIT 24 tm2513375d1_ex24.htm EX-24 6706
  Complete submission text file 0001104659-25-040665.txt   9693
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 46 FREDRICK AVENUE ATHERTON CA 94027
Business Address
Newton Charles W. (Reporting) CIK: 0001866219 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26770 | Film No.: 25882773